452 related articles for article (PubMed ID: 19360510)
1. Quantification of compaction-induced crystallinity reduction of a pharmaceutical solid using 19F solid-state NMR and powder X-ray diffraction.
Liu J; Nagapudi K; Kiang YH; Martinez E; Jona J
Drug Dev Ind Pharm; 2009 Aug; 35(8):969-75. PubMed ID: 19360510
[TBL] [Abstract][Full Text] [Related]
2. Applications of solid-state NMR to pharmaceutical polymorphism and related matters.
Harris RK
J Pharm Pharmacol; 2007 Feb; 59(2):225-39. PubMed ID: 17270076
[TBL] [Abstract][Full Text] [Related]
3. Application of partial least-squares (PLS) modeling in quantifying drug crystallinity in amorphous solid dispersions.
Rumondor AC; Taylor LS
Int J Pharm; 2010 Oct; 398(1-2):155-60. PubMed ID: 20678562
[TBL] [Abstract][Full Text] [Related]
4. Studies on the crystallinity of a pharmaceutical development drug substance.
Byard SJ; Jackson SL; Smail A; Bauer M; Apperley DC
J Pharm Sci; 2005 Jun; 94(6):1321-35. PubMed ID: 15858842
[TBL] [Abstract][Full Text] [Related]
5. Study and characterization of crystalline hydrate/polymorph forms of 5,11-dihydro-11-ethyl-5-methyl-8-(2-(1-oxido-4-quinolinyl)ethyl-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepin-6-one by solid-state NMR and solution NMR.
Gonnella NC; Smoliga JA; Campbell S; Busacca CA; Cerreta M; Varsolona R; Norwood DL
J Pharm Biomed Anal; 2010 Apr; 51(5):1047-53. PubMed ID: 20018474
[TBL] [Abstract][Full Text] [Related]
6. Comparison of X-ray powder diffraction and solid-state nuclear magnetic resonance in estimating crystalline fraction of tacrolimus in sustained-release amorphous solid dispersion and development of discriminating dissolution method.
Rahman Z; Bykadi S; Siddiqui A; Khan MA
J Pharm Sci; 2015 May; 104(5):1777-86. PubMed ID: 25753829
[TBL] [Abstract][Full Text] [Related]
7. Mechanochromism of piroxicam accompanied by intermolecular proton transfer probed by spectroscopic methods and solid-phase changes.
Sheth AR; Lubach JW; Munson EJ; Muller FX; Grant DJ
J Am Chem Soc; 2005 May; 127(18):6641-51. PubMed ID: 15869285
[TBL] [Abstract][Full Text] [Related]
8. A novel approach for calculating starch crystallinity and its correlation with double helix content: a combined XRD and NMR study.
Lopez-Rubio A; Flanagan BM; Gilbert EP; Gidley MJ
Biopolymers; 2008 Sep; 89(9):761-8. PubMed ID: 18428208
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of chemometric algorithms in quantitative X-ray powder diffraction (XRPD) of intact multi-component consolidated samples.
Moore MD; Cogdill RP; Wildfong PL
J Pharm Biomed Anal; 2009 Apr; 49(3):619-26. PubMed ID: 19167855
[TBL] [Abstract][Full Text] [Related]
10. [X-ray diffractometry in the analysis of drugs and pharmaceutical forms].
Bettinetti GP
Boll Chim Farm; 1989 May; 128(5):149-62. PubMed ID: 2690894
[TBL] [Abstract][Full Text] [Related]
11. Solid state NMR perspective of drug-polymer solid solutions: a model system based on poly(ethylene oxide).
Schachter DM; Xiong J; Tirol GC
Int J Pharm; 2004 Aug; 281(1-2):89-101. PubMed ID: 15288346
[TBL] [Abstract][Full Text] [Related]
12. IR spectroscopy together with multivariate data analysis as a process analytical tool for in-line monitoring of crystallization process and solid-state analysis of crystalline product.
Pöllänen K; Häkkinen A; Reinikainen SP; Rantanen J; Karjalainen M; Louhi-Kultanen M; Nyström L
J Pharm Biomed Anal; 2005 Jun; 38(2):275-84. PubMed ID: 15925219
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the acid-base reaction between solid indomethacin and sodium bicarbonate using infrared spectroscopy, X-ray powder diffraction, and solid-state nuclear magnetic resonance spectroscopy.
Chen X; Griesser UJ; Te RL; Pfeiffer RR; Morris KR; Stowell JG; Byrn SR
J Pharm Biomed Anal; 2005 Jul; 38(4):670-7. PubMed ID: 15967295
[TBL] [Abstract][Full Text] [Related]
14. Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction.
Chieng N; Rehder S; Saville D; Rades T; Aaltonen J
J Pharm Biomed Anal; 2009 Jan; 49(1):18-25. PubMed ID: 19081220
[TBL] [Abstract][Full Text] [Related]
15. [Advances in the quantitative analytical methods of drug polymorphism].
Ma LW; Du W; Zhao CS
Yao Xue Xue Bao; 2011 Aug; 46(8):896-903. PubMed ID: 22007512
[TBL] [Abstract][Full Text] [Related]
16. Solid-state NMR in the analysis of drugs and naturally occurring materials.
Paradowska K; Wawer I
J Pharm Biomed Anal; 2014 May; 93():27-42. PubMed ID: 24173236
[TBL] [Abstract][Full Text] [Related]
17. Testing the limits of sensitivity in a solid-state structural investigation by combined X-ray powder diffraction, solid-state NMR, and molecular modelling.
Filip X; Borodi G; Filip C
Phys Chem Chem Phys; 2011 Oct; 13(40):17978-86. PubMed ID: 21931906
[TBL] [Abstract][Full Text] [Related]
18. Study of molecular dynamics and the solid state phase transition mechanism for unsymmetrical thiopyrophosphate using X-ray diffraction, DFT calculations and NMR spectroscopy.
Potrzebowski MJ; Bujacz GD; Bujacz A; Olejniczak S; Napora P; Heliński J; Ciesielski W; Gajda J
J Phys Chem B; 2006 Jan; 110(2):761-71. PubMed ID: 16471600
[TBL] [Abstract][Full Text] [Related]
19. Characterizing challenging microcrystalline solids with solid-state NMR shift tensor and synchrotron X-ray powder diffraction data: structural analysis of ambuic acid.
Harper JK; Grant DM; Zhang Y; Lee PL; Von Dreele R
J Am Chem Soc; 2006 Feb; 128(5):1547-52. PubMed ID: 16448125
[TBL] [Abstract][Full Text] [Related]
20. Conformational isomerism in solid state of AMG 853--structure studies using solid-state nuclear magnetic resonance and X-ray diffraction.
Kiang YH; Nagapudi K; Wu T; Peterson ML; Jona J; Staples RJ; Stephens PW
J Pharm Sci; 2015 Jul; 104(7):2161-8. PubMed ID: 25912152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
